Apyx Medical (APYX) Non-Current Deffered Revenue (2014 - 2026)
Apyx Medical's (APYX) quarterly Non-Current Deffered Revenue came in at $1.1 million in Q1 2026, down 5.28% YoY from $1.2 million in Q1 2025, and up 7.71% on a QoQ basis from $1.0 million in Q4 2025.
Apyx Medical (APYX) Non-Current Deffered Revenue (2014 - 2026) Analysis & Trends
Apyx Medical (APYX) has 12 years of Non-Current Deffered Revenue data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Non-Current Deffered Revenue fell 5.28% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 5.28% YoY) and the FY2025 annual result came in at $1.0 million, down 6.08% from the prior year.
- Non-Current Deffered Revenue rose to $1.1 million in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $1.4 million in Q4 2022 to a low of $1.0 million in Q4 2025.
- A 5-year average of $1.2 million and a median of $1.2 million in 2023 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue surged 62.11% — and 2023, when it fell 11.51%.
- Tracing APYX's Non-Current Deffered Revenue over 5 years: stood at $1.4 million in 2022, then decreased by 11.51% to $1.2 million in 2023, then fell by 10.27% to $1.1 million in 2024, then decreased by 6.08% to $1.0 million in 2025, then grew by 7.71% to $1.1 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $1.1 million (Q1 2026), $1.0 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Apyx Medical | 134.62 Mn | 107.00 Mn | 8.87 Mn | 1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Mn |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.33 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 1.39 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.20 Mn |